Max Jonson

Director of Finance/CFO at BURE EQUITY AB

Net worth: 380 316 $ as of 31/05/2026

58 year

12 connections

Finance

Consumer Services

Health Services

Profile

Max Jonson is currently Director at BioLamina AB, Bure Growth AB, and Skanditek AB. Mr. Jonson is Chief Financial Officer at Bure Equity AB and Bure Equity since 2013.
Former roles include Director at Celemiab Group AB (2014–2016), Dipylon Medical AB (2016–2017), Atle Investment Management AB, and Celemi International AB (2016–2018).
Mr. Jonson was Associate Director-Corporate Finance at SEB Group (Sweden) from 1996 to 2003.
Other former positions include Chief Financial Officer at Orasolv AB (2011–2012), Stockholm School of Economics Ifl (2012–2013), Sse Executive Education (2012–2013), and ACQ Bure AB. Mr. Jonson was Finance Manager at Dpnova AB (2011–2013) and held a Chief Financial Officer role at Yubico AB. Education includes an MBA from The University of Chicago and undergraduate studies at New York University.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
BURE EQUITY AB 0.02%	01/06/2026	12,760 ( 0.02% )	380 316 $	31/05/2026

Max Jonson active positions

Companies	Position	Start
BURE EQUITY AB	Director of Finance/CFO	01/10/2013
Skanditek AB	Director/Board Member	-
BioLamina AB BioLamina AB BiotechnologyHealth Technology Develops, manufactures, and markets cell culture reagents intended for culturing of primary cells	Director/Board Member	-
Bure Growth AB Bure Growth AB Financial ConglomeratesFinance Provides investment services	Director/Board Member	-
Bure Equity (Private Equity) Bure Equity (Private Equity) Investment ManagersFinance Bure Equity invests in middle market companies located in Sweden. The firm targets companies operating across a broad range of sectors and industries. It provides financing for buyout transactions.	Director of Finance/CFO	01/09/2013

All active positions of Max Jonson

Former positions of Max Jonson

Companies	Position	End
Celemi International AB	Director/Board Member	01/01/2018
Dipylon Medical AB Dipylon Medical AB Pharmaceuticals: MajorHealth Technology Engages in the research and development of pharmaceutical products and manufactures medical instruments	Director/Board Member	01/01/2017
Celemiab Group AB Celemiab Group AB Miscellaneous Commercial ServicesCommercial Services Provides consultancy and training services	Director/Board Member	01/01/2016
Sse Executive Education	Director of Finance/CFO	01/01/2013
░░░░░░░░░ ░░░░░░ ░░ ░░░░░░░░░ ░░░	░░░░░░░░ ░░ ░░░░░░░░░░░	░░░░░░░░░░

See the detail of Max Jonson's experience

Training of Max Jonson

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Max Jonson's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	18
Bure Equity AB Bure Equity AB Financial ConglomeratesFinance Provides equity and investment services	Finance
Orasolv AB Orasolv AB Medical/Nursing ServicesHealth Services Engages in the provision of dental care and acquisition of companies in the dental industry	Health Services
The University of Chicago The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
New York University New York University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Bure Equity (Private Equity) Bure Equity (Private Equity) Investment ManagersFinance Bure Equity invests in middle market companies located in Sweden. The firm targets companies operating across a broad range of sectors and industries. It provides financing for buyout transactions.	Finance
Celemiab Group AB Celemiab Group AB Miscellaneous Commercial ServicesCommercial Services Provides consultancy and training services	Commercial Services
Dpnova AB Dpnova AB Medical/Nursing ServicesHealth Services Develops and manufactures dental implants	Health Services
Dipylon Medical AB Dipylon Medical AB Pharmaceuticals: MajorHealth Technology Engages in the research and development of pharmaceutical products and manufactures medical instruments	Health Technology
BioLamina AB BioLamina AB BiotechnologyHealth Technology Develops, manufactures, and markets cell culture reagents intended for culturing of primary cells	Health Technology
Stockholm School of Economics Ifl Stockholm School of Economics Ifl Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Atle Investment Management AB
Bure Growth AB Bure Growth AB Financial ConglomeratesFinance Provides investment services	Finance
Celemi International AB
SEB Group (Sweden)
ACQ Bure AB ACQ Bure AB Financial ConglomeratesFinance Operates as a special purpose acquisition company	Finance
Skanditek AB
Sse Executive Education
Yubico AB Yubico AB Electronics DistributorsDistribution Services Wholesales computers and software	Distribution Services